| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 09/24/2009 | CA2714662A1 Trisubstituted 1,2,4-triazoles as nicotinic acetylcholine receptor modulators |
| 09/23/2009 | EP2102190A1 Compounds and compositions as kinase inhibitors |
| 09/23/2009 | EP2102182A2 Catalytic process for asymmetric hydrogenation |
| 09/23/2009 | EP2102181A1 4-phenyl-pyrane-3,5-diones, 4-phenyl-thiopyrane-3,5-diones and cyclohexanetriones as novel herbicides |
| 09/23/2009 | EP2102173A1 Pyrimidyl derivatives as protein kinase inhibitors |
| 09/23/2009 | EP2102171A1 New pyridazine derivatives with mch antagonistic activity and medicaments comprising these compounds |
| 09/23/2009 | EP2102169A1 Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 09/23/2009 | EP2102168A1 Acylaminopyrazoles for treating cardiovascular diseases |
| 09/23/2009 | EP2102157A1 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 09/23/2009 | EP2101741A2 Solid dispersion comprising a poorly water soluble drug |
| 09/23/2009 | EP1482928B1 Mediators of hedgehog signaling pathways,compositions and uses related thereto |
| 09/23/2009 | EP1467989B1 Proline compounds as ns3-serine protease inhibitors for use in treatment of hepatitis c virus infection |
| 09/23/2009 | CN101541790A Pyrazole analogs |
| 09/23/2009 | CN101538268A Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
| 09/23/2009 | CN101538246A Pyrimidine amide compounds as pgds inhibitors |
| 09/23/2009 | CN101538244A 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity |
| 09/23/2009 | CN100542535C Preparation method of medicinal composition containing 1,3-oxathin cyclopentane nucleoside analogues |
| 09/22/2009 | US7592463 Enantioselective transformation of α,β-unsaturated ketones using chiral organic catalysts |
| 09/22/2009 | US7592450 used to inhibit proliferative conditions, such as cancer and psoriasis, with improved bioavailability and stability |
| 09/22/2009 | US7592368 HIV aspartyl protease inhibitors; solubility, bioavailability; viral and HIV infections |
| 09/22/2009 | US7592359 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists |
| 09/22/2009 | US7592356 and geranylgeranyltransferase inhibitor; 3-chloromethyl-4-cyanobenzyl-5 methyl triazole; antitumor agents; prevent membrane attachment of protein p21ras and block aberrant growth of ras-transformed tumors; capable to inhibit prenylation of Ras proteins, both at enzymatic and cellular level |
| 09/22/2009 | US7592347 Piperazine derivates and their use for the treatment of neurological and psychiatric diseases |
| 09/22/2009 | US7592346 e.g. 3-(3-{2-[4-(2-methyl-5-quinolinyl)-1-piperazinyl]ethyl}phenyl)-1,3-oxazolidin-2-one; serotonin receptor antagonist and inverse agonists, agonists or partial agonists, serotonin reuptake inhibitor; antidepressant, anxiolytic agent |
| 09/22/2009 | US7592338 (1-phenyl-5-propyl-1H-pyrazol-4-yl)-(3-amino-N-cyclopropyl-4-methyl-benzamide)-amine; p38 mitogen-activated protein kinase inhibitor; reduced levels of TNF- alpha expression; antiinfammatory agent: rheumatoid arthritis, psoriasis, multiple sclerosis, endotoxin shock, osteoporosis, Alzheimer's disease |
| 09/22/2009 | US7592337 Di-aryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 09/22/2009 | CA2454584C Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising ep4 agonist as active ingredient |
| 09/22/2009 | CA2419588C Piperidine derivatives for use 2,3-oxidosqualene-lanosterol cyclase inhibitors |
| 09/22/2009 | CA2398274C Adenosine receptor modulators |
| 09/22/2009 | CA2372664C Substituted benzimidazole, the production thereof and the use thereof as means against parasitic protozoa |
| 09/22/2009 | CA2209640C Cycloalkano-pyridines |
| 09/17/2009 | WO2009113600A1 Pyridylaminoacetic acid compound |
| 09/17/2009 | WO2009112550A1 Novel n-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 09/17/2009 | WO2009112523A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides |
| 09/17/2009 | WO2009112461A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/17/2009 | WO2009112395A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 09/17/2009 | WO2009111998A2 Specific impurities of montelukast |
| 09/17/2009 | WO2009111893A1 Substituted pyrimidine compounds and their use as ifnar mediators |
| 09/17/2009 | WO2007129195A3 4-pyrimidine-5-amino-pyrazole compounds |
| 09/17/2009 | US20090233966 Analogues of the Azinomycins as Anti-Tumour Agents and as Prodrugs |
| 09/17/2009 | US20090233952 Substituted cycloalkene derivative |
| 09/17/2009 | US20090233901 Vla-4 inhibitory drug |
| 09/17/2009 | US20090233900 2-aminobenzamide derivative |
| 09/17/2009 | US20090232328 Digital sound processing system for a vehicle |
| 09/17/2009 | US20090229670 Organic photoelectric conversion material and photoelectric conversion element using the same |
| 09/17/2009 | DE102008014077A1 New borrelidin derivatives are janus kinase 3 inhibitors useful e.g. for treating tumor, microbial infection, immune disorder and ophthalmic disease, inhibiting angiogenesis, and manufacturing herbicides and insecticides against arthropods |
| 09/17/2009 | CA2718393A1 Pyridylaminoacetic acid compound |
| 09/17/2009 | CA2718241A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors |
| 09/17/2009 | CA2718166A1 Processes for preparing enantiomerically pure diol and dioxolane compounds |
| 09/17/2009 | CA2716907A1 2-aminoquinolines as 5-ht5a receptor antagonists |
| 09/16/2009 | EP2101365A1 Organic electroluminescent device, display and illuminating device |
| 09/16/2009 | EP2100891A1 Inhibitors of tyrosine kinases |
| 09/16/2009 | EP2100879A1 Novel N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds |
| 09/16/2009 | EP2100507A1 Substance capable of inhibiting cytokinin signaling |
| 09/16/2009 | EP2099789A1 Inhibitors of hiv replication |
| 09/16/2009 | EP2099788A1 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof |
| 09/16/2009 | EP2099770A2 Pyridazinones and furan-containing compounds |
| 09/16/2009 | EP2099765A2 5, 6, or 7-substituted-3-(hetero)arylisoquinolinamine derivatives as antitumor agents |
| 09/16/2009 | EP2099763A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 09/16/2009 | EP2099760A1 Antibacterial quinoline derivatives |
| 09/16/2009 | EP2099757A2 Sulfoximines as kinase inhibitors |
| 09/16/2009 | EP2099755A2 Acetylene derivatives as stearoyl coa desaturase inhibitors |
| 09/16/2009 | EP2099747A1 Radiolabelling via fluorination of aziridines |
| 09/16/2009 | EP1651214B1 Benzimidazole derivatives as mek inhibitors |
| 09/16/2009 | EP1487807B1 Cyano-pyrrolidines as DPP-IV inhibitors |
| 09/16/2009 | EP1411046B1 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same |
| 09/16/2009 | CN101535302A Novel hydroxyindole derivative |
| 09/16/2009 | CN100540548C Dehydrophenylahistins and analogs thereof and the synthesis of dehydrophenylahistins and analogs thereof |
| 09/16/2009 | CN100540546C Arylsulfonyl benzodioxanes for regulating the 5-HT6 receptor, the 5-HT2areceptor or both |
| 09/16/2009 | CN100540538C Large conductance calcium-activated k channel opener |
| 09/16/2009 | CN100540537C Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| 09/15/2009 | US7589232 5-[(3-Cyclopentylpropanoyl)(4-dec-1-ynylbenzyl)amino]-2-hydroxybenzoic acid; inflammatory disorder, obesity and/or metabolic disorders mediated by insulin resistance or hyperglycemia, comprising diabetes, inadequate glucose tolerance, insulin resistance, hyperlipidemia, hypertriglycerimia |
| 09/15/2009 | US7589200 5-Fluoro-4N-phenyl-4-pyrimidineamine compounds |
| 09/15/2009 | US7589119 Less toxicity; side effects redution; administering substituted p-chlorobenzene and a pyrrolethoxybenzene |
| 09/15/2009 | US7589111 Antitumor agents; improved efficacy and less toxicity; taxane having a cyclopentyl ester substituent at C10, a keto substituent at C9, a hydroxy substituent at C2, a 2-thienyl substituent at C3' and an isopropoxycarbamate substituent at C3'. |
| 09/15/2009 | US7589104 delta-opioid receptor agonists as analgesics having reduced side effects and antagonists as immunosuppressants, antiinflammatory agents, neurological, psychiatric , urological and reproductive conditions; e.g. 10-(8-Methyl-8-aza-bicyclo[3.2.1]oct-3-yl)-10H-phenoxazine-3-carboxylic acid diethylamide |
| 09/15/2009 | US7589103 Tricyclic-bridged piperidinylidene derivatives as 8-opioid modulators |
| 09/15/2009 | US7589094 N- (3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 09/15/2009 | US7589092 Prodrugs of heteroaryl compounds |
| 09/15/2009 | US7589078 Anti-viral nucleoside analogs and methods for treating viral infections, especially HIV infections |
| 09/15/2009 | US7588899 Nitropyrimidine derivative for detection and evaluation of kinase inhibitors |
| 09/15/2009 | CA2522323C 3-azabicyclo[3.2.1]octane derivatives as opioid receptor ligands |
| 09/15/2009 | CA2409819C Triazole derivatives |
| 09/15/2009 | CA2374902C Aminoalkyl substituted benzopyran derivatives for treating impaired fundic relaxation |
| 09/11/2009 | WO2009111447A2 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |
| 09/11/2009 | WO2009111442A1 AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 09/11/2009 | WO2009109502A1 2-aminoquinolines |
| 09/11/2009 | WO2009109493A2 2-aminoquinolines |
| 09/11/2009 | WO2009109491A1 2-aminoquinoline derivatives |
| 09/11/2009 | WO2009109477A1 2-aminoquinolines |
| 09/11/2009 | WO2009109270A1 5-oxo-2, 3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes typ 1 and 2 |
| 09/11/2009 | WO2009109258A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | WO2009109230A1 2-aryl and 2 -heteroaryl 4h-1-benzopyran-4-one-6-amidino derivatives for the treatment of arthritis, cancer and related pain |
| 09/11/2009 | WO2008015525A3 An improved process for the preparation of alfuzosin hydrochloride |
| 09/11/2009 | CA2717718A1 Quinoxalinone derivatives as insulin secretion stimulators, methods for obtaining them and use thereof for the treatment of diabetes |
| 09/11/2009 | CA2717453A1 2-aminoquinolines |
| 09/11/2009 | CA2717287A1 5-oxo-2,3,4,5-tetrahydro-benzo[b]oxepine-4-carboxylic acid amides and 2,3-dihydro-benzo[b]oxepine-4-carboxylic acid amides for treatment and prevention of diabetes type 1 and 2 |
| 09/11/2009 | CA2717171A1 Amino-quinoxaline and amino-quinoline compounds for use as adenosine a2a receptor antagonists |
| 09/11/2009 | CA2717138A1 Heterocyclic compound |
| 09/11/2009 | CA2716741A1 Isosorbide derivatives and their use as flavor modifiers, tastants, and taste enhancers |